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Objective: Mesenchymal stem cells (MSCs) are promising candidates for osteoarthritis (OA) therapies,
although their mechanism of action remains unclear. MSCs have recently been discovered to secrete anti-
inﬂammatory cytokines and growth factors. We studied the paracrine effects of MSCs on OA cartilage and
synovial explants in vitro.
Design: MSC-conditioned medium was prepared by stimulating primary human MSCs with tumour
necrosis factor alpha (TNFa) and (50 ng/ml each). Human synovium and cartilage explants were cultured
in MSC-conditioned medium or in control medium, containing the same amount of added TNFa and IFNg
but not incubated with MSCs. Explants were analyzed for gene expression and the production of nitric
oxide (NO). The presence of the inhibitor of nuclear factor kappa B alpha (IkBa) was assessed by Western
blot analysis.
Results: Synovial explants exposed to MSC-conditioned medium showed decreased gene expression of
interleukin-1 beta (IL-1b), matrix metalloproteinase (MMP)1 and MMP13, while suppressor of cytokine
signaling (SOCS)1 was upregulated. In cartilage, expression of IL-1 receptor antagonist (IL-1RA) was
upregulated, whereas a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)5 and
collagen type II alpha 1 (COL2A1) were downregulated. MSC-conditioned medium reduced NO produc-
tion in cartilage explants and the presence of IkBa was increased in synoviocytes and chondrocytes
treated with MSC-conditioned medium.
Conclusions: In an inﬂammatory environment, MSCs secrete factors which cause multiple anti-
inﬂammatory effects and inﬂuence matrix turnover in synovium and cartilage explants. Thereby, the
presented data encourage further study of MSCs as a treatment for joint diseases.
 2012 OsteoArthritis Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is characterized by a catabolic and inﬂam-
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is Society International. Publishedstructurally modify OA processes or prevent progression of the
disease1. The use of mesenchymal stem cells (MSCs) as a treatment
option in cartilage regenerative therapies is under extensive
investigation2. MSCs have chondrogenic potential and are experi-
mentally being implanted in focal cartilage defects, showing
promising results3. In OA, more generalized cartilage lesions and
joint inﬂammation are present, thereby limiting the usefulness of
focal treatments. In order to treat the joint as a whole, MSCs have
been injected intra-articularly in pre-clinical and some initial
clinical studies as a treatment for OA4e6. Animal studies have
shown beneﬁcial effects of MSCs on cartilage morphology and
histology in various OA models4,5,7. Interestingly, studies using cell
tracking in cartilage repair show only limited cartilage formation byby Elsevier Ltd. All rights reserved.
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applied cells are mostly retrieved from other articular structures,
like the synovium. Apparently, the intra-articularly injected MSCs
only occasionally differentiate into chondrocytes to actively
produce extracellular matrix. This implies a different OA modifying
mechanism, like inﬂuencing the micro-environment by paracrine
actions, stimulating locally present progenitor cells to repair OA
damage or by attracting circulating endogenous progenitor cells to
enable repair8. We studied the inﬂuence of MSCs on their local
micro-environment by the secretion of bioactive factors. Some of
these factors, including interleukin-6 (IL-6), IL-10, indoleamine 2,3-
dioxygenase (IDO), hepatocyte growth factor (HGF) and trans-
forming growth factor beta (TGFb), have immunomodulatory
properties9,10,whereas others are involved in extracellular matrix
turnover such as matrix metalloproteinases (MMPs) and their
inhibitors, tissue inhibitors of metalloproteinases (TIMPs)11. In
addition, trophic effects of MSCs to stimulate chondrocyte prolif-
eration andmatrix deposition have been shown12. Aim of our study
was to explore the protective effects of MSCs on OA related
processes in a controlled and standardized environment, by
investigating the paracrine effects of MSCs on OA synovium and
cartilage explants in vitro. These paracrine effects were studied by
means of MSC-conditioned medium; medium containing factors
secreted by MSCs. Since MSCs increase their immunomodulatory
properties in response to an inﬂammatory stimulus, and inﬂam-
mation plays a substantial role in OA pathology, we challenged our
cells with the inﬂammatory cytokines tumour necrosis factor alpha
(TNFa) and interferon gamma (IFNg)13,14. We measured the pres-
ence of factors in MSC-conditioned medium involved in inﬂam-
mation, tissue regeneration and extracellular matrix turnover.
Furthermore, we evaluated the effects of MSC-conditionedmedium
on osteoarthritic cartilage and synovium by analyses of the
expression of genes related to inﬂammation and matrix turnover,
the production of nitric oxide (NO) and prostaglandin E2 (PGE2)
and activity of p38 mitogen-activated protein (MAP) kinase and
nuclear factor kappa B (NFkB) pathways. These two pathways are
major orchestrators in transducing inﬂammatory and catabolic
signals in joint degeneration15,16.
Materials and methods
Cells and tissue preparation
Human MSCs (hMSCs) were isolated and cultured from hepa-
rinized femoral-shaft marrow aspirate of nine patients undergoing
total hip arthroplasty (after written informed consent; protocol #
MEC-2004-142) using previously described procedures17. This
procedure was previously conﬁrmed to yield MSC on the basis of
morphological criteria, expression of CD105 marker and absence of
CD34 marker and an adipogenic, osteogenic and chondrogenic
differentiation potential17. Cells were seeded at a density of
2300 cells/cm2 and cultured in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) containing 1 g/l glucose, 10% fetal calf serum (FCS), 50 mg/
ml gentamicin, 1.5 mg/ml fungizone, 1 ng/ml ﬁbroblast growth
factor-2 and 0.1 mM L-ascorbic acid 2-phosphate (MSC culture
medium). Human synovial explants (approximately 10 mm3) and
cartilage explants (approximately 70 mm3) were obtained as
surgical waste material from seven patients undergoing total knee
replacement surgery. All patients implicitly consented to the use of
these tissues for scientiﬁc research (protocol # MEC-2004-322).
Explants were pre-cultured for 48 h in DMEM containing 1 g/l
glucose, 2% FCS, 50 mg/ml gentamicin and 1.5 mg/ml fungizone.
Synoviocytes and chondrocytes were isolated from synovium and
cartilage respectively as described previously18 by treating explants
from either tissue with 0.2% protease (SigmaeAldrich, Zwijndrecht,Netherlands) and subsequent overnight digestion in DMEM con-
taining 4.5 g/l glucose, 10% FCS, 50 mg/ml gentamicin and 1.5 mg/ml
fungizone, supplemented with 0.15% collagenase B (Roche Diag-
nostics, Mannheim, Germany).
Conditioned medium preparation and explant culture
Subconﬂuent hMSCmonolayer cultures (passage two) were used
to obtain conditioned medium. MSC-conditioned medium from four
donors was prepared by incubating hMSCs for 24 h in MSC culture
medium. To stimulate the secretion of immunomodulatory factors
by MSCs, TNFa and IFNg (50 ng/ml each, PeproTech, London, UK)
were added to the MSC culture medium for ﬁve other MSC donors.
After 24 h the medium was collected and centrifuged for 8 min at
700g to remove cellular debris. MSCs and the supernatant of the
medium (MSC-conditioned medium) were harvested separately and
stored at 80C until further use. MSC processing for gene expres-
sion analysis is described later in this section. Control (uncondi-
tioned)mediumwasmade of plain MSC culture medium for the ﬁrst
four MSC donors, and MSC culture medium supplemented with
TNFa/IFNg (50 ng/ml each) for the ﬁve cytokine-stimulated MSC
donors. Both control media, with or without TNFa/IFNg, were
incubated without MSCs at 37 C for 24 h and stored at 80 C until
further use. TNFa/IFNg. Except for the absence of MSCs during
incubation, the control medium was treated identical to MSC-
conditioned medium. In experiments using MSC-conditioned
media from non-stimulated donors, control medium without
TNFa/IFNg was used. Stimulated MSC-conditioned media were
compared to control medium with TNFa/IFNg.
Synovium and cartilage explants were cultured in MSC-
conditioned medium or in control medium for 48 h. Explants from
each synovium or cartilage donor were cultured in triplicate samples
per condition in 24-well plates in a total volume of 1.0 ml, consisting
of 500 ml MSC-conditionedmedium and 500 ml freshly added DMEM
containing 50 mg/ml gentamicin and 1.5 mg/ml fungizone. Depending
on theamountof explantmaterial that couldbeobtained fromagiven
donor, explants were cultured in conditioned medium from one to
four separate MSC donors. After culturing for 48 h, explants for gene
expression analyses and media were harvested and stored at 80C
until further use.MSC-conditionedmediumwithout TNFa/IFNg from
four MSC donors was used on two synovium and cartilage donors.
Conditioned medium from MSCs stimulated with TNFa/IFNg from
ﬁve MSC donors was used on ﬁve synovium and cartilage donors.
We additionally studied the effect of MSCs in a co-culture
system of synovium and cartilage explants19. In short, synovium
and cartilage explants from the same donor were cultured together,
thereby preventing direct contact between cartilage and synovium
by using Millicell ﬁlter inserts with a pore size of 0.4 mm (Millipore,
Amsterdam, the Netherlands). These experiments were performed
on synovium and cartilage from one donor in triplicates using
pooled MSC-conditioned media from ﬁve different MSC donors.
Gene expression analysis
The frozen explants were processed using a Mikro-
Dismembrator S (B. Braun Biotech International GmbH, Melsun-
gen, Germany). RNA from explants was extracted using RNA-Bee
(TEL-TEST, Friendswood, USA) according to manufacturer’s guide-
lines and subsequently precipitatedwith chloroform 20% (v/v). RNA
from MSCs was extracted using RNeasy lysis buffer (Qiagen, Venlo,
the Netherlands) and beta-mercaptoethanol 1% (v/v). All RNAwere
further puriﬁed using RNeasy Micro Kit (Qiagen, Hilden, Germany)
with on-column DNA digestion. Nucleic acid content was deter-
mined spectrophotometrically (NanoDrop ND1000; Isogen Life
Science, IJsselstein, The Netherlands). Complementary DNA and
G.M. van Buul et al. / Osteoarthritis and Cartilage 20 (2012) 1186e11961188polymerase chain reactions (PCRs) were performed as described
before20. Reverse transcriptase (RT)-PCR primer nucleotide
sequences are listed in Table I. Data were normalized to a best
keeper index (BKI) of three reference genes glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), ubiquitin C (UBC), hypoxan-
thine-guanine phosphoribosyltransferase (HPRT1)21. Relative
expression levels were calculated using the 2DDCt method22.NO and PGE2 measurements
NO and PGE2 secretion by synovium and cartilage was analyzed
in the cryopreserved media from the synovium and cartilage
explants culture experiments. NO secretion was determined by
quantifying its derived product, nitrite, in medium using a spec-
trophotometric method based upon the Griess reaction23. Brieﬂy,
100 ml of culture medium or sodium nitrite (NaNO2) standard
dilutions were mixed with 100 ml of Griess reagent (0.5% sulpha-
nilamide, 0.05% naphtyl ethylenediamine dihydrochloride, 2.5%
H3PO4). The absorptionwas measured at 540 nm. PGE2 secretion in
the media was determined using the PGE2 assay (R&D systems,
Minneapolis, MN, USA) according to manufacturer’s guidelines. NO
measurements were performed on triplicate samples from ﬁve
synovium and cartilage donors separately. For the PGE2 assay the
triplicate samples per condition were pooled before measurement
to obtain values from four synovium and four cartilage donors.Western blotting for p38 and NFkB signaling pathway analyses
The amount of native and phosphorylated p38 MAP kinase and
the amount of inhibitor of nuclear factor kappa B alpha (IkBa) were
determined by Western blot analysis of total protein extracts fromTable I
Primer nucleotide sequences of the tested genes
Gene Primer
IL-6 Fw: TCGAGCCCACCGGGAACGAA
Rv: GCAGGGAAGGCAGCAGGCAA
HGF Fw: GGCTGGGGCTACACTGGATTG
Rv: CCACCATAATCCCCCTCACAT
TGFb-1 Fw: GTGACAGCAGGGATAACACACTG
Rv: CATGAATGGTGGCCAGGTC
IDO Assay-on-demand (Hs00158027.m1,
Applied Biosystems, Capelle a/d IJssel,
the Netherlands)
IL-1b Fw: CCCTAAACAGATGAAGTGCTCCTT
Rv: GTAGTCGGATGCCGCCAT
IL-1RA Fw: AACAGAAAGCAGGACAAGCG
Rv: CCTTCGTCAGGCATATTGGT
TNFa Fw: GCCGCATCGCCGTCTCCTAC
Rv: AGCGCTGAGTCGGTCACCCT
SOCS1 Fw: CCCTGGTTGTTGTAGCAGCTT
Rv: TTGTGCAAAGATACTGGGTATATGT
SOCS3 Fw: TCGGACCAGCGCCACTT
Rv: CACTGGATGCGCAGGTTCT
MMP1 Fw: CTCAATTTCACTTCTGTTTTCTG
Rv: CATCTCTGTCGGCAAATTCGT
MMP13 Fw: CTCAATTTCACTTCTGTTTTCTG
Rv: CATCTCTGTCGGCAAATTCGT
TIMP1 Fw: TGCCGCATCGCCGAGAT
Rv: ATGGTGGGTTCTCTGGTG
TIMP2 Fw: ATGGTGGGTTCTCTGGTG
Rv: CGGTACCACGCACAGGA
ADAMTS4 Fw: CAAGGTCCCATGTGCAACGT
Rv: CATCTGCCACCACCAGTGTCT
ADAMTS5 Fw: CAAGGTCCCATGTGCAACGT
Rv: CATCTGCCACCACCAGTGTCT
COL2A1 Fw: GGCAATAGCAGGTTCACGTACA
Rv: CGATAACAGTCTTGCCCCACTT
ACAN Fw: TCGAGGACAGCGAGGCC
Rv: TCGAGGGTGTAGCGTGTAGAGAﬁbroblast-like synoviocytes and chondrocytes exposed to MSC-
conditioned medium. Synoviocytes and chondrocytes from two
donors each were used. Subconﬂuent monolayers of synoviocytes
and chondrocytes (passage 2e4) were cultured in pooled MSC-
conditioned medium (from ﬁve MSC donors) or control medium
for either 10 min (for IkBa determination) or for 3 h (for p38 MAP
kinase signaling). The chosen incubation times were based on an
experiment using different durations of IFNg/TNFa treatment to
predeﬁne the optimal time-point to evaluate possible paracrineMSC
effects (data not shown). Based on previous reports, IFNg/TNFa
dependent IkBa degradation was determined in a period ranging
from 5min to 1 h and p38MAP kinase phosphorylation in a period of
3e24 h24,25.
Total protein fractions were isolated using Mammalian Protein
Extraction Reagent (M-PER) (#78501, Thermo Scientiﬁc) with 1%
protease inhibitor complete (Roche, Manheim, Germany). Protein
concentrations were determined by the bicinchoninic acid (BCA)
protein assay (Pierce Chemical, Rockford, IL, USA). For each sample,
8 mg of total protein fraction was separated by 10% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels and
transferred on polyvinylidene ﬂuoride (PVDF) membranes by
Western blotting. Membranes were blocked for 2 h in 0.1% tris-
buffered saline-tween (TBS-T) containing 5% dry milk powder,
washed three times in 0.1% TBS-T and incubated with primary
antibodies against a-Tubulin, p38 MAP kinase, phosphorylated p38
(all diluted 1:1000; respectively 2148, 9212 and 9211, Cell Signaling
Technology, Leiden, the Netherlands) or IkBa (1:500; sc-371, Santa
Cruz Biotechnology, Heidelberg, Germany) overnight at 4C
following manufacturer’s protocol. An anti-rabbit horseradish
peroxidase (HPR)-linked secondary antibody (1:1000; 7074, Cell
Signaling) was added and incubated for 1 h at room temperature.
The blots were visualized by means of SuperSignal Chemilumi-
nescent system (34077, Thermo Scientiﬁc) using manufacturer’s
instruction. Image analysis and quantiﬁcation were performed
using the National Institute of Health Image J freeware (release
1.44X; http://rsb.info.nih.gov/ij/).
Analyses of MSCs and conditioned media
Stimulated and non-stimulated MSCs from four donors were
analyzed for gene expression of IL-6, TIMP2, HGF, TGFb-1 and IDO as
described in the gene expression analysis section. TIMP2, HGF, IL-6
and TGFb-1 protein levels were measured in stimulated and non-
stimulated MSC-conditioned media from three donors by means
of enzyme-linked immunosorbent assays (ELISAs) (R&D systems,
Abingdon, UK) according to the protocol supplied by the manu-
facturer. All factors were corrected for the amounts present in
standard MSC culture medium. To determine the amount of IDO
enzymatic activity in MSC-conditioned media, the level of its
metabolite, kynurenine, was measured spectrophotometrically as
described before26. In brief, 100 ml of 30% trichloroacetic acid
(SigmaeAldrich, St. Louis, USA) was added to 200 ml of culture
supernatant, which was incubated at 50C for 30 min, and then
centrifuged at 10,000g for 5 min. 75 ml of supernatant was then
added to an equal volume of Ehrlich’s reagent (100 mg p-dime-
thylbenzaldehyde and 5 ml glacial acetic acid; SigmaeAldrich St.
Louis, USA) and optical density was measured at 490 nm.
Data analyses
All data are presented as mean standard deviation. Statistical
analyses were performed using a mixed model analysis of variance
(ANOVA) [statistical package social sciences (SPSS) 17.0.2; SPSS Inc.,
Chicago, USA], which takes the within donor correlation into
account. Treatment using MSC-conditioned media vs control
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statistically considered as independent observations. The synovium
or cartilage donors were considered a random factor and
measurements of the separate samples per donor were regarded
correlated observations. Donor was included into the model to
adjust for absolute differences in expression levels between explant
donors. A log-transformation was applied to all gene expression
data before statistical analyses to approach normal data distribu-
tion. A P-value< 0.05 was considered statistically signiﬁcant.
Results
MSCs display immunomodulatory properties in response to
inﬂammatory cytokine exposure
To determine which factors might be involved in the anti-
inﬂammatory effects caused by the MSC-conditioned medium, we
analyzed TNFa/IFNg stimulated and non-stimulated MSCs for gene
expression and protein secretion of various immunomodulatory
factors and growth factors. Stimulation of MSC’s with theFig. 1. Inﬂuence of TNFa/IFNg stimulation on MSC gene expression (A) and MSC secretions (B
and IFNg for 24 h. Media from TNFa/IFNg stimulated and unstimulated MSCs were analy
expression data are presented as boxplots for four experiments performed in triplicate. Ce
performed in triplicate. *P< 0.05; **P< 0.01; ***P< 0.005.inﬂammatory cytokines upregulated gene expression of IDO and IL-
6, while TIMP2 and TGFb-1were markedly downregulated [Fig. 1(A);
P< 0.001 for all genes]. HGF, IL-1b and TIMP1 gene expressions were
not signiﬁcantly altered by the priming procedure (data not shown).
The amount of secreted IL-6, HGF, TIMP2, TGFb-1 and IDO enzy-
matic activity inconditionedmediumfromTNFa/IFNg stimulatedand
unstimulated MSCs was measured [Fig. 1(B)]. IL-6 was signiﬁcantly
elevated in TNFa/IFNg stimulated MSC-conditioned medium
(approximately 15-fold, P< 0.001), as was IDO activity (approxi-
mately 60-fold, P< 0.001) compared with non-stimulated condi-
tionedmedium.HGF, TIMP2andTGFb-1were found inequal amounts
in both stimulated and non-stimulated conditioned medium.
Factors secreted by stimulated MSCs modify genes related to
inﬂammation and matrix turnover in synovium and cartilage
We evaluated whether factors secreted by MSCs affected
inﬂammatory and catabolic processes in osteoarthritic synovium
and cartilage. First we performed experiments in which we
cultured synovium and cartilage explants in conditioned medium). In order to stimulate the immunomodulatory capacity, MSCs were treated with TNFa
zed for various factors and corrected for control medium containing 10% FCS. Gene
ll secretion data are presented as means standard deviations for three experiments
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(unstimulated MSC-conditioned medium). None of the genes
analyzed (mentioned later in this section) in either synovium or
cartilage were signiﬁcantly affected or affected more than twofold
by this unstimulated MSC-conditioned medium (Figs. 2, 3).
Therefore, we did not include this condition in our further exper-
iments. All further presented experiments were performed using
conditionedmedium from TNFa/IFNg stimulated MSCs (designated
as MSC-conditioned medium).
In synovial explants, MSC-conditioned medium downregulated
IL-1b (P ¼ 0.014), MMP1 (P ¼ 0.034) and MMP13 (P ¼ 0.016) gene
expressions, while suppressor of cytokine signaling (SOCS)1
expression was upregulated (P ¼ 0.002) compared to control
medium (Fig. 4). MSC-conditioned medium did not evidently affect
IL-1 receptor antagonist (IL-1RA) or SOCS3 gene expression of
synovial explants. In cartilage explants, MSC-conditioned medium
upregulated IL-1RA gene expression, while a disintegrin and met-
alloproteinase with thrombospondin motifs (ADAMTS)5 and
collagen type II alpha 1 (COL2A1) expressions were downregulated
(Fig. 5; P< 0.001 for all genes). ADAMTS4 and SOCS3 were non-Fig. 2. Effects of factors secreted by non-stimulated MSCs on expression of genes related to
are presented as boxplots for three experiments, in which MSC-conditioned medium from th
treated for 48 h.signiﬁcantly downregulated by 2.5-fold and 1.6-fold respectively.
SOCS1,MMP1,MMP13 and aggrecan (ACAN) expressions of cartilage
explants were not clearly inﬂuenced by factors secreted by MSCs.
The interaction between cartilage and synovium is an important
aspect in the pathogenesis of OA. To evaluate the validity of our
results in a more complex environment resembling more closely
the in vivo situation, we exposed co-cultures of cartilage and
synovium explants to MSC-conditioned medium (pooled from ﬁve
MSC donors). Control experiments using pooled MSC-conditioned
medium on separate cartilage and synovium explants revealed
effects on gene expression level matching the effects observed
using MSC-conditioned medium from individual donors (data not
shown). MSC-conditioned medium affected gene expression levels
in our co-culture model similar to our single explant culture model
(Supp. Fig. 1(A, B)). Synovium showed downregulation of IL-1b
(2.7-fold) and upregulation of SOCS1 (4.6-fold). MMP1 and MMP13
appeared uninﬂuenced by MSC-conditioned medium. In cartilage,
gene expression of IL-1RA (3.3-fold) and SOCS1 (1.8-fold) was
upregulated, whereas ADAMTS5 (2.0-fold) and COL2A1 (1.9-fold)
were downregulated by MSC-conditioned medium compared toinﬂammation and matrix degradation in human osteoarthritic synovial explants. Data
ree MSC donors was applied to triplicate explants from three OA donors; explants were
Fig. 3. Effects of factors secreted by non-stimulated MSCs on expression of genes related to inﬂammation and matrix degradation in human osteoarthritic cartilage explants. Data
are presented as boxplots for three experiments, in which MSC-conditioned medium from three MSC donors was applied to triplicate explants from three OA donors; explants were
treated for 48 h.
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results obtained in separate cultures using synovial or cartilage
tissue, indicating that MSCs can have an effect in a more complex
system that better mimics in vivo conditions.
Effects of MSCs on NO and PGE2 secretion
Cartilage explants secreted more NO than synovial explants,
whereas the latter produced the most PGE2 [Fig. 6(A, B)]. In carti-
lage explants, MSC-conditioned medium exerted a small but
signiﬁcant (P¼ 0.005) decrease in the NO secretion from
112 20 mM to 9318 mM, together with a 50% decrease in PGE2
secretion (not statistically signiﬁcant) from 0.98 0.78 ng/ml to
0.49 0.18 ng/ml. No effects were seen in synovial explants.
Effects of MSCs on intracellular signaling pathways
To evaluate possible signaling pathways that are inﬂuenced by
MSCs, we cultured isolated human synoviocytes and chondrocytes
in MSC-conditioned medium and analyzed phosphorylated p38
MAP kinase and IkBa amounts by Western blot. MSC-conditioned
medium did not inﬂuence p38 MAP kinase phosphorylation in
either cell-type [Fig. 7(A)]. Non-phosphorylated p38 MAP kinase
was constitutively expressed for all conditions (data not shown), as
was a-Tubulin. Treatment with MSC-conditioned medium
increased the presence of IkBa [Fig. 7(B)] in both cell-types, thereby
indicating that MSCs secrete factors which inhibit NFkB activation.Discussion
OA is a disabling disease where many catabolic and inﬂamma-
tory processes play a role27. MSCs have chondrogenic potential, but
can also play a role in immunomodulation and tissue regeneration
by secretion of soluble factors28. In this study we showed for the
ﬁrst time such an effect of MSCs on OA tissues. Exposure of synovial
and cartilage explants to MSC-secreted factors resulted in gene
expression proﬁles and production of factors consistent with anti-
inﬂammatory and anti-catabolic activity in these tissues. This
included beneﬁcial effects on the expression of genes related to
inﬂammation (IL-1b, IL-1RA, SOCS1) and matrix degradation
(MMP1, MMP13 and ADAMTS5) in synovium or cartilage. These
results were conﬁrmed in a co-culture model of synovium and
cartilage, a system resembling more closely the in vivo situation.
Next to the effects on gene expression, MSC-conditioned medium
reduced production of the inﬂammatory mediator NO in cartilage
explants and increased presence of IkBa in synoviocytes and
chondrocytes. The phosphorylation and degradation of IkBa, which
normally binds NFkB, is an essential and ﬁrst step in activation of
the NFkB pathway. NFkB has been reported to induce gene
expression of, amongst others, IL-1b, TNFa, MMP1, MMP3 and
MMP13, indicating it’s role as a main pathway involved in inﬂam-
mation and matrix degradation16.
We needed to stimulate MSCs to achieve secretion of sufﬁcient
amounts of immunomodulatory factors to inﬂuence OA cartilage
and synovial explants. We challenged our cells with TNFa and IFNg
Fig. 4. Effects of factors secreted by TNFa/IFNg stimulated MSCs on expression of genes related to inﬂammation and matrix degradation in human osteoarthritic synovial explants.
Data are presented as boxplots for ﬁve experiments, in which MSC-conditioned medium from ﬁve MSC donors was applied to triplicate explants from ﬁve OA donors; explants were
treated for 48 h; *P< 0.05; **P< 0.01; ***P< 0.005.
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OA research27,29 and the presence of IFNg producing T-cells in OA
synovium has been indicated30. To study whether this model
reﬂected pathological OA processes, we tested the effects of TNFa/
IFNg on explants from three of the ﬁve patients (Supp. Figs. 2, 3).
Several inﬂammatory and catabolic effects were observed in both
tissues at gene expression level, together with a signiﬁcantly
increased NO and PGE2 production as well as p38 phosphorylation
and IkBa degradation. Taken together, this indicates that TNFa/IFNg
induced various processes which are relevant in OA16,27.
The stimulated MSCs in our experiments produced IL-6, HGF,
TIMP2 and TGFb-1 and displayed a high enzymatic IDO activity. The
selection of this panel of factors was based on the fact that they are
known to be secreted by MSCs at high levels and their known
involvement in general inﬂammation processes or joint metabo-
lism29,31. IDO is an important factor for the inhibition of T-cell
proliferation and has been reported to decrease joint inﬂamma-
tion32. The role of IL-6 in OA, however, is controversial (reviewed in
Ref. 27). Although it is in general considered an inﬂammatorymediator, IL-6 deﬁcient mice were shown to have a lower proteo-
glycan synthesis with a higher incidence of subchondral bone
sclerosis33, and increased cartilage damage which was reduced by
IL-6 injection34. These results indicate possible advantageous roles
of IL-6 in immune modulation. The other factors we determined in
MSC-conditionedmedium, HGF, TIMP2 and TGFb-1, all play a role in
tissue regeneration and cartilage matrix turnover35e37.
MSC-conditioned medium upregulated SOCS1 gene expression
in synovium and caused a trend toward SOCS3 downregulation in
cartilage. SOCS1 is a negative regulator of macrophage and
dendritic cell activation, while SOCS3 is a positive regulator of these
immune cells (reviewed in Ref. 38). Furthermore, the presence of
SOCS1 has been reported to limit joint destruction in inﬂammatory
arthritis, whereas SOCS3 upregulation in chondrocytes has been
shown to contribute to cartilage damage39,40.
OA synovium and cartilage are known to have a very hetero-
geneous gene expression pattern between patients or between
different areas within the same patient41,42. Due to this high vari-
ation it is challenging to obtain consistent results. Nevertheless, we
Fig. 5. Effects of factors secreted by TNFa/IFNg stimulated MSCs on expression of genes related to inﬂammation and matrix turnover in human osteoarthritic cartilage explants.
Data are presented as boxplots for ﬁve experiments, in which MSC-conditioned medium from ﬁve MSC donors was applied to triplicate explants from ﬁve OA donors; explants were
treated for 48 h; ***P< 0.005.
Fig. 6. Inﬂuence of factors secreted by TNFa/IFNg stimulated MSCs on NO (A) and PGE2 secretion (B) by synovium (left panels) and cartilage (right panels) explants. Data are
presented as boxplots for ﬁve experiments (NO) or four experiments (PGE2), in which MSC-conditioned medium from ﬁve MSC donors was applied to triplicate explants from ﬁve,
respectively four, OA donors. Regarding NO measurements, all triplicate samples were measured individually; regarding PGE2 measurements, triplicates were pooled and measured
in duplicate. Explants were treated for 48 h; **P< 0.01.
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Fig. 7. Inﬂuence of factors secreted by TNFa/IFNg stimulated MSCs on p38 MAP kinase phosphorylation (A) and IkBa presence (B) in both synoviocytes and chondrocytes was
measured by Western blot. Presence of IkBa was increased in both cell-types by MSC-conditioned medium, thereby indicating an inhibitory effect on NFkB activation. Data are
presented as means standard deviations for single values obtained in two experiments; cells were treated for 3 h for p38 MAP kinase evaluation or 10 min for IkBa analysis.
G.M. van Buul et al. / Osteoarthritis and Cartilage 20 (2012) 1186e11961194found signiﬁcant effects of factors secreted by MSCs on inﬂam-
matory and matrix degrading processes. Although no clear effects
of stimulated MSC-conditioned medium were observed on various
other genes and factors we analyzed, many trends were seen
pointing toward an overall decreased inﬂammatory and catabolic
environment. Synovial explants exhibited a lower average gene
expression of SOCS3 and a higher expression of IL-1RA after treat-
ment with factors secreted by MSCs. In cartilage, SOCS1was higher
expressed and ADAMTS4, MMP1 and MMP13 genes were lower
expressed on average in MSC-conditioned medium treated
samples. Next to this, in cartilage a trend toward a diminished PGE2
production was found. Even though these effects were small and
not signiﬁcant, partially due to a low sample size, they supported
our conﬁdence in the potential of MSCs as environmental modu-
lators and their beneﬁcial role in modifying OA tissues.
Wu et al. found a beneﬁcial trophic effect of MSCs on
glycosaminoglycan (GAG) production by bovine chondrocyte
pellets in a non-inﬂammatory environment12. We did not
observe an effect on ACAN gene expression and found a down-
regulation of COL2A1 by MSC-conditioned medium. It could be
hypothesized that in an inﬂammatory environment, MSCs are
mainly triggered to counteract inﬂammation instead of stimu-
lating matrix formation. This is further supported by the
observed increase of the immunomodulatory factors IDO and IL-
6 in conditioned media from TNFa/IFNg stimulated MSCs,
although the amount of growth factors between stimulated and
non-stimulated MSCs remained similar. Possible anabolic effects
of secreted growth factors may become more obvious in condi-
tions without inﬂammation.
We have not assessed whether our observed paracrine effects
were speciﬁc for MSCs. It was recently shown that skin ﬁbroblasts
suppress inﬂammation in an arthritis model43, while others found
no immunosuppressive properties of skin ﬁbroblasts in a sepsis
model44. We did not study ﬁbroblasts since we consider this cell-
type unsuitable for intra-articular application. MSCs have the
advantage of being immune privileged, and they have the capacity
of chondrogenic differentiation, a mechanism of action which is
likely to be at least part of their regenerative capacity for cartilage
repair45. Next to this, MSCs are locally present in multiple joint
tissues46 and are able to react to the joint environment, as shown by
the increased presence of MSCs in synovium and synovial ﬂuidafter joint injury47,48. This suggests that the increased intra-
articular presence of MSCs is part of a natural healing process.
The administration of MSCs in an osteoarthritic joint could be
a therapy for OAmimicking and enhancing this healing process and
thereby provide a natural and autologous treatment for OA.
To our knowledge, this is the ﬁrst study indicating that factors
secreted by MSCs cause multiple anti-inﬂammatory and anti-
catabolic effects in osteoarthritic cartilage and synovium. We per-
formed culture experiments for 48 h, a common time-point to
evaluate processes at a gene expression level in our group49.
Generally, this time-point is too soon to evaluate effects at a protein
level on matrix components like proteoglycans or ACAN. Therefore
we evaluated proteins which are known to respond very fast and
induce other processes such as NO, PGE2, IkBa or p38 MAP kinase.
Further studies are warranted to investigate the effects on struc-
tural properties of the cartilage using longer-term cultures and
in vivo experiments.
MSC-conditioned medium undoubtedly contained many more
factors than the ones we have measured, including for instance
TNFa stimulated gene-650. The whole panel of bioactive factors
probably works in concert to achieve the anti-osteoarthritic effects
observed in our study. Since intra-articularly injected MSCs have
been shown to survive in an intra-articular environment up to at
least 4e6 weeks5,7, they could provide the ultimate long term
delivery of a cocktail of OA modifying factors.
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